HOME Press Releases Clinical Decision Support Systems Market worth 1,519.2 Million USD by 2021



Clinical Decision Support Systems Market worth 1,519.2 Million USD by 2021


The report "Clinical Decision Support Systems Market by Component (Services, Software), Delivery Mode, Product Type (Integrated, Standalone), Model (Knowledge-Based), Type (Therapeutic, Diagnostic), User Interactivity (Active, Passive), Application - Forecasts to 2021", This report studies the global clinical decision support systems market over the forecast period of 2016 to 2021. This market is expected to reach USD 1,519.2 Million by 2021 from USD 856.3 Million in 2016, at a CAGR of 12.2%.

                 Request Sample                 Request Sample

Browse 104 market data tables and 35 figures spread through 203 pages and in-depth TOC on “Clinical Decision Support Systems Market by Component (Services, Software), Delivery Mode, Product Type (Integrated, Standalone), Model (Knowledge-Based), Type (Therapeutic, Diagnostic), User Interactivity (Active, Passive), Application - Forecasts to 2021”
http://www.marketsandmarkets.com/Market-Reports/clinical-decision-support-systems-market-18085342.html
Early buyers will receive 10% customization on reports.

In this report, the global CDSS market is segmented on the basis of component, delivery mode, product, type, model, user interactivity, application, and region.

The services segment is estimated to account for the largest share of the global CDSS market, by component, in 2016. However, due to the need for periodic software upgradation, the software segment is expected to witness the highest growth during the forecast period.

Web-based CDSS segment is expected to command the largest share of the global CDSS market, by delivery mode, in 2016. However, the market for cloud-based solutions is expected to witness the highest growth rate in the forecast period.

Integrated CDSS segment is expected to account for the largest share of the CDSS market, by product, in 2016 and also witness the highest growth during the forecast period.

Therapeutic CDSS segment is expected to command the largest share of the global CDSS market, by type, in 2016 and is estimated to grow at the highest rate in the forecast period.
Knowledge-based CDSS segment is expected to command the largest share of the global CDSS market, by model, in 2016 and is estimated to grow at the highest rate in the forecast period.

By interactivity, active CDSS segment is expected to command the largest share of the global CDSS market in 2016, and is estimated to grow at the highest rate in the forecast period.

The conventional CDSS segment is expected to command the largest share of the global CDSS market, by application, in 2016. However, the advanced CDSS segment is estimated to grow at the highest rate in the forecast period. This is owing to these systems performing additional functions such as population health management, financial decision support, assisting clinicians in real-time evidence based decision making, treatment planning and protocol validation among others.

Geographically, the global CDSS market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest market share in 2016, followed by Europe and Asia-Pacific. The Asia-Pacific market is relatively nascent; however it is projected to be the fastest growing market in the forecast period.

Cerner Corporation (U.S.), McKesson Corporation (U.S.), Epic Systems Corporation Inc. (U.S.), Medical Information Technology, Inc. (U.S.), Philips Healthcare (Netherlands), Allscripts Healthcare Solutions, Inc. (U.S.), Wolters Kluwer Health (U.S.), Zynx Health (U.S.), Elsevier B.V. (Netherlands), and International Business Machines (IBM) Corporation (U.S.) are the key players in the global CDSS market.

About MarketsandMarkets

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports